Trial Search Results

Allo BMT in Advanced Leukemia or High Grade Lymphoma

To evaluate the role of ablative allogeneic hematopoietic cell transplantation in the treatment of advanced leukemia or lymphoma.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: ablative allogeneic hematopoietic cell transplantation

Phase:

N/A

Eligibility


Inclusion Criteria:HLA identical donor

   - adequate organ function

   - other life threatening disease

Ages Eligible for Study

N/A - 50 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Referrals
6507230822
Not Recruiting